Microsatellite instability in ductal carcinoma in situ of the breast

被引:0
作者
Walsh, T
Chappell, SA
Shaw, JA
Walker, RA
机构
[1] Univ Leicester, Glenfield Hosp, Dept Pathol, Breast Canc Res Unit, Leicester LE3 9QP, Leics, England
[2] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England
关键词
ductal carcinoma in situ; microdissection; microsatellite instability; DM-1; alterations; mismatch repair protein expression;
D O I
10.1002/(SICI)1096-9896(199805)185:1<18::AID-PATH41>3.0.CO;2-G
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Microsatellite instability (MI+) is associated with defects in mismatch repair, resulting in a 'mutator' phenotype and the development and progression of cancer. MI+ has been documented in invasive breast carcinomas. This study was undertaken to determine whether MI+ is found in the early non-invasive form of breast cancer, ductal carcinoma in situ (DCIS). We examined microdissected ducts from 23 cases of DCIS with 11 markers comprising mono-, di-, and trinucleotide repeats from six chromosomal regions. Five tumours (22 per cent) displayed MI+ at two or more loci, in all ducts examined. A further seven (30 per cent) tumours showed alterations at a single locus (the DM-1 trinucleotide), and for two of these, heterogeneity between ducts was observed. Alterations at microsatellite repeat motifs in the coding regions of four cancer-associated genes (TGF beta RII, IGFIIR, BAX, and E2F-4) were not observed. Immunohistochemistry revealed that there was no loss of reactivity: for the mismatch repair proteins, MLH1, MSH2, and PMS2, in the DCIS cases. In general, MI+ tumours and those with alterations at the DM-1 microsatellite were predominantly of higher nuclear grade and expressing c-erbB-2, suggesting that aberrations in DNA repair functions may lead to the acquisition of a more aggressive phenotype in breast cancer. (C) 1998 John Wiley & Sons, Ltd.
引用
收藏
页码:18 / 24
页数:7
相关论文
共 44 条
  • [1] CLUES TO THE PATHOGENESIS OF FAMILIAL COLORECTAL-CANCER
    AALTONEN, LA
    PELTOMAKI, P
    LEACH, FS
    SISTONEN, P
    PYLKKANEN, L
    MECKLIN, JP
    JARVINEN, H
    POWELL, SM
    JEN, J
    HAMILTON, SR
    PETERSEN, GM
    KINZLER, KW
    VOGELSTEIN, B
    DELACHAPELLE, A
    [J]. SCIENCE, 1993, 260 (5109) : 812 - 816
  • [2] ALDAZ CM, 1995, CANCER RES, V55, P3976
  • [3] IMMUNOHISTOCHEMICAL DEMONSTRATION OF C-ERBB-2-PROTEIN IN MAMMARY DUCTAL CARCINOMA INSITU
    BARTKOVA, J
    BARNES, DM
    MILLIS, RR
    GULLICK, WJ
    [J]. HUMAN PATHOLOGY, 1990, 21 (11) : 1164 - 1167
  • [4] DUCTAL CARCINOMA IN-SITU - ASSESSMENT OF NECROSIS AND NUCLEAR MORPHOLOGY AND THEIR ASSOCIATION WITH BIOLOGICAL MARKERS
    BOBROW, LG
    HAPPERFIELD, LC
    GREGORY, WM
    MILLIS, RR
    [J]. JOURNAL OF PATHOLOGY, 1995, 176 (04) : 333 - 341
  • [5] MOLECULAR-BASIS OF MYOTONIC-DYSTROPHY - EXPANSION OF A TRINUCLEOTIDE (CTG) REPEAT AT THE 3' END OF A TRANSCRIPT ENCODING A PROTEIN-KINASE FAMILY MEMBER
    BROOK, JD
    MCCURRACH, ME
    HARLEY, HG
    BUCKLER, AJ
    CHURCH, D
    ABURATANI, H
    HUNTER, K
    STANTON, VP
    THIRION, JP
    HUDSON, T
    SOHN, R
    ZEMELMAN, B
    SNELL, RG
    RUNDLE, SA
    CROW, S
    DAVIES, J
    SHELBOURNE, P
    BUXTON, J
    JONES, C
    JUVONEN, V
    JOHNSON, K
    HARPER, PS
    SHAW, DJ
    HOUSMAN, DE
    [J]. CELL, 1992, 68 (04) : 799 - 808
  • [6] MICROSATELLITE INSTABILITY AND PATHOLOGICAL ASPECTS OF BREAST-CANCER
    CONTEGIACOMO, A
    PALMIROTTA, R
    DEMARCHIS, L
    PIZZI, C
    MASTRANZO, P
    DELRIO, P
    PETRELLA, G
    FIGLIOLINI, M
    BIANCO, AR
    FRATI, L
    CAMA, A
    MARIANICOSTANTINI, R
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (04) : 264 - 268
  • [7] DeMarchis L, 1997, CLIN CANCER RES, V3, P241
  • [8] Eshleman James R., 1995, Current Opinion in Oncology, V7, P83
  • [9] Fujii H, 1996, CANCER RES, V56, P1493
  • [10] GLEBOV OK, 1994, CANCER RES, V54, P3703